Human papillomavirus infections in laryngeal cancer

Head and Neck

Volumn 33, Issue 4, 2011, Pages 581-586

  Torrente, Mariela C ^a   Rodrigo, Juan P ^b,c   Haigentz Jr , Missak ^d   Dikkers, Frederik G ^e   Rinaldo, Alessandra ^f   Takes, Robert P ^g   Olofsson, Jan ^h   Ferlito, Alfio ^f  

^a UNIVERSITY OF CHILE   (Chile)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY OF UDINE   (Italy)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

HPV; infection; larynx; papillomatosis; squamous cell carcinoma; verrucous carcinoma

Indexed keywords

PROTEIN E7; PROTEIN P16; PROTEIN P53; VIRUS DNA; WART VIRUS VACCINE;

ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TOBACCO DEPENDENCE;

CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; DNA, VIRAL; GENOTYPE; HUMANS; LARYNGEAL NEOPLASMS; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 79952912123     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21421     Document Type: Article

References (56)

1. Ullman EV,. On the aetiology of the laryngeal papilloma. Acta Otolaryngol 1923; 5: 317-334.
2. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H,. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3: 1151-1157.
3. Löning T, Meichsner M, Milde-Langosch K, et al. HPV DNA detection in tumours of the head and neck: a comparative light microscopy and DNA hybridization study. ORL J Otorhinolaryngol Relat Spec 1987; 49: 259-269. (Pubitemid 18011758)
4. Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009; 31: 1393-1422.
5. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269. (Pubitemid 351480538)
6. Ragin CCR, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820. (Pubitemid 47417302)
7. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. (Pubitemid 36159887)
8. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995; 64: 1-378.
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475. (Pubitemid 40270113)
10. Giroglou T, Florin L, Schäfer F, Streeck RE, Sapp M,. Human papillomavirus infection requires cell surface heparin sulfate. J Virol 2001; 75: 1565-1570. (Pubitemid 32094716)
11. Stubenrauch F, Laimins LA,. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999; 9: 379-386. (Pubitemid 30184507)
12. Kashima H, Mounts P, Leventhal B, Hruban RH,. Site of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 1993; 102: 580-583. (Pubitemid 23236703)
13. Bernard BA, Bailly C, Lenoir MC, Darmon M, Thierry F, Yaniv M,. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol 1989; 63: 4317-4324. (Pubitemid 19229429)
14. Münger K, Howley PM,. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213-228. (Pubitemid 35351540)
15. Duensing S, Münger K,. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004; 109: 157-162. (Pubitemid 38240914)
16. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997; 35: 1304-1310. (Pubitemid 27216785)
17. Depuydt CE, Boulet GAV, Horvath CAJ, Benoy IH, Vereecken AJ, Bogers JJ,. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007; 11: 881-891. (Pubitemid 47313308)
18. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC,. Generation of type specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998; 11: 971-977. (Pubitemid 28487217)
19. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimens. Int J Cancer 2007; 121: 2465-2472. (Pubitemid 350022416)
20. Scully C, Field JK, Tanzawa H,. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000; 36: 311-327. (Pubitemid 30427251)
21. Pande P, Mathur M, Shukla NK, Ralhan R,. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998; 34: 396-403. (Pubitemid 28440304)
22. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3633. (Pubitemid 26272001)
23. Eike A, Buchwald C, Rolighed J, Lindeberg H,. Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol 1995; 20: 171-173.
24. Bouda M, Gorgoulis VG, Kastrinakis NG, et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-653. (Pubitemid 30436801)
25. Sand L, Jalouli J, Larsson PA, Hirsch JM,. Human papilloma viruses in oral lesions. Anticancer Res 2000; 20: 1183-1188. (Pubitemid 30240698)
26. Terai M, Hashimoto K, Yoda K, Sata T,. High prevalence of human papillomaviruses in the normal oral cavity of adults. Oral Microbiol Immunol 1999; 14: 201-205. (Pubitemid 29351034)
27. Lawton G, Thomas S, Schonrock J, Monsour F, Frazer I,. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 1992; 21: 265-269.
28. Baseman JG, Koutsky LA,. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 (Suppl 1): S16-24. (Pubitemid 40332585)
29. Jeong WJ, Park SW, Shin M, et al. Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis. Head Neck 2009; 31: 1095-1101.
30. Barnes L, Yunis EJ, Krebs FJ III, Sonmez-Alpan E,. Verruca vulgaris of the larynx. Demonstration of human papillomavirus types 6/11 by in situ hybridization. Arch Pathol Lab Med 1991; 115: 895-899.
31. Acar B, Babademez MA, Karabulut H, Karasen RM,. An unusual cause of dysphonia: laryngeal verruca vulgaris. B-ENT 2009; 5: 183-187.
32. Brandsma JL, Steinberg BM, Abramson AL, Winkler B,. Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res 1986; 46: 2185-2188. (Pubitemid 16117929)
33. Abramson AL, Brandsma J, Steinberg B, Winkler B,. Verrucous carcinoma of the larynx. Possible human papillomavirus etiology. Arch Otolaryngol 1985; 111: 709-715. (Pubitemid 16195499)
34. Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE,. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope 1993; 103: 416-420. (Pubitemid 23133899)
35. Fliss DM, Noble-Topham SE, McLachlin M, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 1994; 104: 146-152. (Pubitemid 24052042)
36. Lõpez-Amado M, García-Caballero T, Lozano-Ramírez A, Labella-Caballero T,. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx. J Laryngol Otol 1996; 110: 742-747. (Pubitemid 26334973)
37. Syrjänen S, Syrjänen K, Mäntyjärvi R, Collan Y, Kärjä J,. Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization. ORL J Otorhinolaryngol Relat Spec 1987; 49: 175-186. (Pubitemid 18011747)
38. Salam MA, Rockett J, Morris A,. General primer-mediated polymerase chain reaction for simultaneous detection and typing of human papillomavirus DNA in laryngeal squamous cell carcinomas. Clin Otolaryngol 1995; 20: 84-88.
39. Ma XL, Ueno K, Pan ZM, Hi SZ, Ohyama M, Eizuru Y,. Human papillomavirus DNA sequences and p53 over-expression in laryngeal squamous cell carcinomas in Northeast China. J Med Virol 1998; 54: 186-191. (Pubitemid 28102809)
40. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999; 30: 274-283. (Pubitemid 29125146)
41. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
42. de Oliveira DE, Bacchi MM, Macarenco RS, Tagliarini JV, Cordeiro RC, Bacchi CE,. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol 2006; 126: 284-293. (Pubitemid 44162576)
43. Gungor A, Cincik H, Baloglu H, Cekin E, Dogru S, Dursun E,. Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J Laryngol Otol 2007; 121: 772-774. (Pubitemid 47093958)
44. Morshed K, Polz-Dacewicz M, Szymanski M, Polz D,. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 2008; 265 (Suppl 1): S89-S96.
45. Smith EM, Summersgill KF, Allen J, et al. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 2000; 109: 1069-1076.
46. García-Milián R, Hernández H, Panadé L, et al. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 1998; 118: 754-758. (Pubitemid 28505615)
47. Fukushima K, Ogura H, Watanabe S, Yabe Y, Masuda Y,. Human papillomavirus type 16 DNA detected by the polymerase chain reaction in non-cancer tissues of the head and neck. Eur Arch Otorhinolaryngol 1994; 251: 109-112. (Pubitemid 24126268)
48. Rihkanen H, Peltomaa J, Syrjänen S,. Prevalence of human papillomavirus (HPV) DNA in vocal cords without laryngeal papillomas. Acta Otolaryngol 1994; 114: 348-351. (Pubitemid 24198908)
49. Hobbs CGL, Sterne JAC, Bailey M, Heyderman RS, Birchall MA, Thomas SJ,. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 259-266. (Pubitemid 44141088)
50. Psyrri A, DiMaio D,. Human papillomavirus in cervical and head and neck cancer. Nat Clin Pract Oncol 2008; 5: 24-31. (Pubitemid 351512426)
51. Laco J, Slaninka I, Jirásek M, Celakovskà P, Vosmiková H, Ryska A,. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol Res Pract 2008; 204: 545-552.
52. Baumann JL, Cohen S, Evjen AN, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009; 119: 1531-1537.
53. Clayman GL, Stewart MG, Weber RS, El-Naggar AK, Grimm EA,. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg 1994; 120: 743-748. (Pubitemid 24217588)
54. Torrente MC, Ojeda JM,. Exploring the relation between human papilloma virus and larynx cancer. Acta Otolaryngol 2007; 127: 900-906. (Pubitemid 47345803)
55. Holsinger FC, Kies MS, Diaz EM Jr, et al. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 2009; 27: 1976-1982.
56. Holsinger FC, Lin HY, Bassot V, Laccourreye O,. Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. Cancer 2009; 115: 3909-3918.